dc.contributor.author | Suer, Kaya | |
dc.contributor.author | Tulek, Necla Eren | |
dc.contributor.author | Tutuncu, Emin Ediz | |
dc.contributor.author | Koruk, Suda Tekin | |
dc.contributor.author | AYGEN, BİLGEHAN | |
dc.contributor.author | DEMİRTÜRK, NEŞE | |
dc.contributor.author | Kinikli, Sami | |
dc.contributor.author | Kaya, Ali | |
dc.contributor.author | Yildirmak, Taner | |
dc.contributor.author | Korkmaz, Fatime | |
dc.contributor.author | URAL, ONUR | |
dc.contributor.author | AKHAN, SILA | |
dc.contributor.author | GÜNAL, ÖZGÜR | |
dc.contributor.author | Tuna, Nazan | |
dc.contributor.author | Kose, Sukran | |
dc.contributor.author | Gonen, Ibak | |
dc.contributor.author | Batirel, Ayse | |
dc.contributor.author | Tuncer, Gunay | |
dc.contributor.author | Tosun, Dervis | |
dc.contributor.author | ŞENER, ALPER | |
dc.contributor.author | Aynioglu, Aynur | |
dc.contributor.author | Altunok, Elif Sargin | |
dc.contributor.author | Ormen, Bahar | |
dc.contributor.author | Turker, Nesrin | |
dc.contributor.author | Saltoglu, Nese | |
dc.contributor.author | Bulut, Cemal | |
dc.contributor.author | SIRMATEL, FATMA | |
dc.contributor.author | Ulcay, Asim | |
dc.contributor.author | Karagoz, Ergenekon | |
dc.contributor.author | Gurbuz, Yunus | |
dc.date.accessioned | 2021-03-06T07:21:36Z | |
dc.date.available | 2021-03-06T07:21:36Z | |
dc.date.issued | 2016 | |
dc.identifier.citation | Gurbuz Y., Tulek N. E. , Tutuncu E. E. , Koruk S. T. , AYGEN B., DEMİRTÜRK N., Kinikli S., Kaya A., Yildirmak T., Suer K., et al., "Evaluation of Dual Therapy in Real Life Setting in Treatment-Naive Turkish Patients with HCV Infection: A Multicenter, Retrospective Study", BALKAN MEDICAL JOURNAL, cilt.33, ss.18-26, 2016 | |
dc.identifier.issn | 2146-3123 | |
dc.identifier.other | av_dc4aa1d8-cbd2-46f2-80c0-69c42cad3000 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/145196 | |
dc.identifier.uri | https://doi.org/10.5152/balkanmedj.2015.15859 | |
dc.description.abstract | Background: Before the introduction of direct-acting antivirals in the treatment of chronic hepatitis C patients, the combination of peginterferon alpha and ribavirin was the standard therapy. Observational studies that investigated sustained virological response (SVR) rates by these drugs yielded different outcomes. | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Temel Tıp Bilimleri | |
dc.subject | Klinik Tıp | |
dc.subject | TIP, GENEL & İÇECEK | |
dc.title | Evaluation of Dual Therapy in Real Life Setting in Treatment-Naive Turkish Patients with HCV Infection: A Multicenter, Retrospective Study | |
dc.type | Makale | |
dc.relation.journal | BALKAN MEDICAL JOURNAL | |
dc.contributor.department | Diskapi Yildirim Beyazit Training & Research Hospital , , | |
dc.identifier.volume | 33 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 18 | |
dc.identifier.endpage | 26 | |
dc.contributor.firstauthorID | 229597 | |